Jiangsu gdk Biotechnology Co., Ltd.
SHH: 688670.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jianhui Zhang
- Employees
- 452
- Headquarters
- Taizhou, China
- IPO year
- 2021
- Market cap
- CN¥2.3B
- Website
- https://www.gdkbio.com
Loading 688670…
Loading profile data…Frequently asked questions about 688670
What does Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) do?
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenz...
Where does 688670.SS trade?
Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) trades on the Shanghai Stock Exchange.
What sector is 688670.SS in?
Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Jiangsu gdk Biotechnology Co., Ltd.?
Jianhui Zhang is the chief executive officer of Jiangsu gdk Biotechnology Co., Ltd. (688670.SS).
Where is Jiangsu gdk Biotechnology Co., Ltd. headquartered?
Jiangsu gdk Biotechnology Co., Ltd. is headquartered in China.
Does 688670.SS pay a dividend?
Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 688670.SS go public?
Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) completed its initial public offering in 2021.